博爾特生物治療公司
US ˙ NasdaqCM ˙ US0977021049

簡介

本頁面提供了有關 Randall C Schatzman 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Randall C Schatzman已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:BOLT / Bolt Biotherapeutics, Inc. Chief Executive Officer, Director 12,859
US:ALDR / Alder BioPharmaceuticals, Inc. President and CEO, Director 200,000
如何解讀這些圖表

以下圖表顯示了在Randall C Schatzman進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

BOLT / Bolt Biotherapeutics, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 BOLT / Bolt Biotherapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2023-12-06 BOLT Schatzman Randall C 2,500 0.7820 125 15.6400 1,955 117 1.5000 -1,768 -90.41
2023-06-06 BOLT Schatzman Randall C 2,500 1.1815 125 23.6300 2,954
2022-12-06 BOLT Schatzman Randall C 2,500 1.1815 125 23.6300 2,954
2022-06-06 BOLT Schatzman Randall C 2,500 1.6405 125 32.8100 4,101
2021-02-09 BOLT Schatzman Randall C 1,500 20.0000 75 400.0000 30,000

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

BOLT / Bolt Biotherapeutics, Inc. Insider Trades
BOLT / Bolt Biotherapeutics, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 BOLT / Bolt Biotherapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

BOLT / Bolt Biotherapeutics, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Randall C Schatzman 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2024-02-06 2023-12-06 5 BOLT Bolt Biotherapeutics, Inc.
Common Stock
P - Purchase 2,500 12,859 24.13 0.78 1,955 10,056
2024-02-06 2023-06-06 5 BOLT Bolt Biotherapeutics, Inc.
Common Stock
P - Purchase 2,500 10,359 31.81 1.18 2,954 12,239
2023-02-07 2022-12-06 5 BOLT Bolt Biotherapeutics, Inc.
Common Stock
P - Purchase 2,500 7,859 46.65 1.18 2,954 9,285
2023-02-07 2022-06-06 5 BOLT Bolt Biotherapeutics, Inc.
Common Stock
P - Purchase 2,500 5,359 87.44 1.64 4,101 8,791
2022-02-23 2022-02-18 4 BOLT Bolt Biotherapeutics, Inc.
Stock Option (Right to Buy)
A - Award 630,000 630,000
2021-02-09 2021-02-09 4 BOLT Bolt Biotherapeutics, Inc.
Common Stock
P - Purchase 1,500 1,500 20.00 30,000 30,000
2021-02-08 2021-02-04 4 BOLT Bolt Biotherapeutics, Inc.
Stock Option (Right to Buy)
A - Award 340,000 340,000
2018-02-21 2018-02-16 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 200,000 200,000
2017-02-13 2017-02-09 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -30,000 78,181 -27.73
2017-02-13 2017-02-09 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -30,000 115,172 -20.67 25.03 -750,756 2,882,202
2017-02-13 2017-02-09 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 30,000 145,172 26.05 1.65 49,500 239,534
2017-01-31 2017-01-27 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 275,000 275,000
2017-01-31 2016-11-30 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
A - Award 404 115,172 0.35 20.20 8,161 2,326,474
2016-11-09 2016-11-07 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -10,000 108,181 -8.46
2016-11-09 2016-11-07 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -10,000 114,768 -8.01 25.16 -251,605 2,887,620
2016-11-09 2016-11-07 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 10,000 124,768 8.71 1.65 16,500 205,867
2016-10-05 2016-10-03 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -8,181 0 -100.00
2016-10-05 2016-10-03 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -2,700 114,768 -2.30 31.55 -85,189 3,621,103
2016-10-05 2016-10-03 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -5,481 117,468 -4.46 30.95 -169,622 3,635,306
2016-10-05 2016-10-03 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 8,181 122,949 7.13 1.26 10,349 155,530
2016-09-06 2016-09-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -10,000 8,181 -55.00
2016-09-06 2016-09-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -10,000 114,768 -8.01 32.48 -324,820 3,727,894
2016-09-06 2016-09-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 10,000 124,768 8.71 1.26 12,650 157,832
2016-08-03 2016-08-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -10,000 18,181 -35.48
2016-08-03 2016-08-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -16 114,768 -0.01 32.69 -523 3,751,766
2016-08-03 2016-08-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Commom Stock
S - Sale X -4,816 114,784 -4.03 31.68 -152,570 3,636,334
2016-08-03 2016-08-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -5,168 119,600 -4.14 30.65 -158,420 3,666,230
2016-08-03 2016-08-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 10,000 124,768 8.71 1.26 12,650 157,832
2016-07-27 2016-07-25 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -10,000 28,181 -26.19
2016-07-27 2016-07-25 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -10,000 114,768 -8.01 28.08 -280,805 3,222,743
2016-07-27 2016-07-25 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 10,000 124,768 8.71 1.26 12,650 157,832
2016-06-03 2016-06-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -10,000 38,181 -20.76
2016-06-03 2016-06-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -1,965 114,768 -1.68 30.26 -59,460 3,472,822
2016-06-03 2016-06-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -8,035 116,733 -6.44 29.51 -237,084 3,444,371
2016-06-03 2016-06-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 10,000 124,768 8.71 1.26 12,650 157,832
2016-05-24 2016-05-24 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -4,017 48,181 -7.70
2016-05-24 2016-05-24 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -4,017 112,947 -3.43 28.03 -112,588 3,165,656
2016-05-24 2016-05-24 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 4,017 116,964 3.56 1.26 5,082 147,959
2016-05-24 2016-05-23 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -2,997 52,198 -5.43
2016-05-24 2016-05-23 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -2,997 112,947 -2.58 28.01 -83,952 3,163,871
2016-05-24 2016-05-23 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 2,997 115,944 2.65 1.26 3,791 146,669
2016-05-24 2016-05-20 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -2,986 55,195 -5.13
2016-05-24 2016-05-20 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -2,986 112,947 -2.58 28.01 -83,635 3,163,544
2016-05-24 2016-05-20 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 2,986 115,933 2.64 1.26 3,777 146,655
2016-04-18 2016-04-18 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -4,514 58,181 -7.20
2016-04-18 2016-04-18 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -4,514 112,947 -3.84 28.08 -126,742 3,171,269
2016-04-18 2016-04-18 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 4,514 117,461 4.00 1.26 5,710 148,588
2016-04-18 2016-04-15 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -5,486 62,695 -8.05
2016-04-18 2016-04-15 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -8,538 0 -100.00
2016-04-18 2016-04-15 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -14,024 112,947 -11.05 28.11 -394,150 3,174,421
2016-04-18 2016-04-15 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 5,486 126,971 4.52 1.26 6,940 160,618
2016-04-18 2016-04-15 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 8,538 121,485 7.56 0.38 3,287 46,772
2016-04-18 2016-04-14 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -11,462 8,538 -57.31
2016-04-18 2016-04-14 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -11,462 112,947 -9.21 28.01 -321,075 3,163,883
2016-04-18 2016-04-14 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 11,462 124,409 10.15 0.38 4,413 47,897
2016-02-02 2016-01-29 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 236,500 236,500
2016-01-06 2016-01-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -10,000 20,000 -33.33
2016-01-06 2016-01-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -2,020 111,579 -1.78 31.95 -64,546 3,565,340
2016-01-06 2016-01-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -7,980 113,599 -6.56 31.35 -250,201 3,561,726
2016-01-06 2016-01-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 10,000 121,579 8.96 0.38 3,850 46,808
2015-12-03 2015-12-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -10,000 30,000 -25.00
2015-12-03 2015-12-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -10,000 111,579 -8.23 37.24 -372,431 4,155,548
2015-12-03 2015-12-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 10,000 121,579 8.96 0.38 3,850 46,808
2015-11-04 2015-11-02 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -10,000 40,000 -20.00
2015-11-04 2015-11-02 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -5,222 109,921 -4.54 34.44 -179,839 3,785,547
2015-11-04 2015-11-02 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -1,400 115,143 -1.20 33.40 -46,765 3,846,191
2015-11-04 2015-11-02 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -3,378 116,543 -2.82 32.70 -110,462 3,811,003
2015-11-04 2015-11-02 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 10,000 119,921 9.10 0.38 3,850 46,170
2015-05-28 2015-05-26 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -50,000 50,000 -50.00
2015-05-28 2015-05-26 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale -50,000 109,921 -31.27 38.96 -1,948,085 4,282,709
2015-05-28 2015-05-26 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise 50,000 159,921 45.49 0.38 19,250 61,570
2015-01-28 2015-01-27 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -63,578 109,921 -36.64 28.71 -1,825,165 3,155,557
2015-01-28 2015-01-26 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 130,000 130,000
2015-01-28 2015-01-26 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -36,422 173,499 -17.35 27.93 -1,017,234 4,845,671
2014-07-10 2014-07-08 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 80,000 80,000
2014-05-09 2014-05-07 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 90,909 90,909
2014-05-07 3 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
416,968
2014-05-07 3 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
416,968
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)